Tampere, Finland

Jorma Petajisto


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jorma Petajisto: Innovator in Multi-Phase Screening Technology

Introduction

Jorma Petajisto is a notable inventor based in Tampere, Finland. He has made significant contributions to the field of engineering, particularly in the area of multi-phase screening technology. His innovative approach has led to advancements that improve the efficiency and quality of screening processes.

Latest Patents

Jorma Petajisto holds a patent for a "Method for controlling a multi-phase screening apparatus." This invention provides a method and apparatus for controlling a multi-step screening apparatus that regulates accept, reject, and dilution flows based on the flow measured in the accept channel of the first screening step. The design allows for a simpler control unit to be utilized, resulting in higher quality accept outputs than previously achievable. This patent showcases his expertise in creating effective solutions for complex engineering challenges.

Career Highlights

Throughout his career, Jorma has been associated with Valmet Corporation, a leading company in the field of industrial technology. His work at Valmet has allowed him to apply his innovative ideas in practical settings, contributing to the company's reputation for excellence in engineering solutions.

Collaborations

Jorma Petajisto has collaborated with talented professionals such as Jouko Hautala and Juhani Valli. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Jorma Petajisto's contributions to multi-phase screening technology exemplify the impact of innovation in engineering. His patent and work at Valmet Corporation highlight his commitment to advancing industrial processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…